Trial Profile
A phase 3 trial comparing the efficacy and safety of LEO 90100 aerosol foam with the aerosol foam vehicle used twice weekly as long-term maintenance therapy in subjects with psoriasis vulgaris. A 12-month, international, multi-centre, randomised, vehicle controlled, double-blind, 2-arm, parallel group trial.
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 15 Jul 2016
Price :
$35
*
At a glance
- Drugs Betamethasone-dipropionate/calcipotriol (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- Sponsors LEO Pharma
- 15 Jul 2016 New trial record